ES2062529T3 - Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales. - Google Patents

Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales.

Info

Publication number
ES2062529T3
ES2062529T3 ES90907580T ES90907580T ES2062529T3 ES 2062529 T3 ES2062529 T3 ES 2062529T3 ES 90907580 T ES90907580 T ES 90907580T ES 90907580 T ES90907580 T ES 90907580T ES 2062529 T3 ES2062529 T3 ES 2062529T3
Authority
ES
Spain
Prior art keywords
treatment
realization
viral infections
aliphatic alcohols
medicine intended
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90907580T
Other languages
English (en)
Inventor
David H Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avanir Pharmaceuticals Inc
Original Assignee
Avanir Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/345,084 external-priority patent/US4874794A/en
Application filed by Avanir Pharmaceuticals Inc filed Critical Avanir Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2062529T3 publication Critical patent/ES2062529T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Abstract

SE PRESENTA UN TRATAMIENTO ANTIVIRICO SISTEMATICO QUE UTILIZA UNA CLASE RESTRINGIDA DE ALCOHOLES MONOHIDRICOS SATURADOS DE CADENA EN LINEA ALIFATICOS QUE TIENEN DE 20 A 26, PREFERIBLEMENTE DE 22 A 26, CARBONOS EN LA CADENA EN COMPOSICIONES FISIOLOGICAMENTE COMPATIBLES PARA SER INYECTADOS O INTRODUCIDOS EN LA MEMBRANA TRANSMUCOSA DE SERES HUMANOS U OTROS ANIMALES.
ES90907580T 1989-04-28 1990-04-16 Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales. Expired - Lifetime ES2062529T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/345,084 US4874794A (en) 1989-04-28 1989-04-28 Inflammatory disease treatment
US07/431,304 US5071879A (en) 1989-04-28 1989-11-02 Systemic antiviral treatment

Publications (1)

Publication Number Publication Date
ES2062529T3 true ES2062529T3 (es) 1994-12-16

Family

ID=26994246

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90907580T Expired - Lifetime ES2062529T3 (es) 1989-04-28 1990-04-16 Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales.

Country Status (8)

Country Link
US (1) US5071879A (es)
EP (1) EP0469064B1 (es)
JP (1) JP3064010B2 (es)
AT (1) ATE96662T1 (es)
DE (1) DE69004425T2 (es)
DK (1) DK0469064T3 (es)
ES (1) ES2062529T3 (es)
WO (1) WO1990013287A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380754A (en) * 1988-02-29 1995-01-10 Virotex Corporation Topical composition enhancing healing of viral lesions
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US5952392A (en) * 1996-09-17 1999-09-14 Avanir Pharmaceuticals Long-chain alcohols, alkanes, fatty acids and amides in the treatment of burns and viral inhibition
US5948822A (en) * 1996-12-17 1999-09-07 Lidak Pharmaceuticals Treatment of hyperproliferative skin disorders with C18 to C26 alphatic alcohols
US20050203187A1 (en) * 1998-06-01 2005-09-15 Verbiscar Anthony J. Formulations useful for the treatment of varicella zoster virus infections and methods for the use thereof
ATE298345T1 (de) 1999-09-03 2005-07-15 Cabby Business Inc Effizientes verfahren zur herstellung sehr reiner sterinen
US20030018074A1 (en) * 2001-07-06 2003-01-23 Robert Kleiman Antiviral composition and treatment method
US20040033982A1 (en) * 2001-10-16 2004-02-19 Katz David H Viral inhibition by n-docosanol
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
US20050074443A1 (en) * 2003-10-03 2005-04-07 Treadwell Benjamin V. Methods of attenuating autoimmune disease and compositions useful therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459233A (en) * 1973-08-29 1976-12-22 Inst Rech Chim Biolog Medicament containing a higher alkanol
DE3318989C2 (de) * 1982-05-28 1996-11-21 Eisai Co Ltd ß,gamma-Dihydropolyprenylalkoholderivate und diese enthaltende Arzneimittel und deren Verwendung
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
IT1203934B (it) * 1987-04-17 1989-02-23 Consiglio Nazionale Ricerche Composizioni farmaceutiche contenenti alcoli superiori per il trattamento di patologie della prostata
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury

Also Published As

Publication number Publication date
DE69004425T2 (de) 1994-02-24
JP3064010B2 (ja) 2000-07-12
DK0469064T3 (da) 1994-03-21
ATE96662T1 (de) 1993-11-15
JPH05501542A (ja) 1993-03-25
US5071879A (en) 1991-12-10
EP0469064B1 (en) 1993-11-03
WO1990013287A1 (en) 1990-11-15
DE69004425D1 (de) 1993-12-09
EP0469064A1 (en) 1992-02-05

Similar Documents

Publication Publication Date Title
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
PT100779A (pt) Acidos amidazolil-alcenoico, composicoes farmaceuticas que os contem e seu uso
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
ES2117390T3 (es) Sales de un acido graso poliinsaturado y formulaciones farmaceuticas que las contienen.
CY2007034I1 (el) Εμβολιο εναντια στον ανθρωπινο ϊο θηλωματος (τυπος 18)
ATE131730T1 (de) Nukleosidanalogen enthaltende antiviren- zubereitungen
IT1224795B (it) Uso dell'acetil d-carnitina nel trattamento terapeutico del glaucoma e composizioni farmaceutiche utili in tale trattamento
MX9102353A (es) N,o-sulfados de heparosanos, su procedimiento de preparacion y las composiciones farmaceuticas que contienen.
ES2062529T3 (es) Uso de alcoholes alifaticos, de c-20 a c-26, para la realizacion de un medicamento destinado al tratamiento de infecciones virales.
ITRM910002A0 (it) Uso dell'acetil l-carnitina nel trattamento terapeutico del coma e composizioni farmaceutiche utili in tale trattamento.
FR2674754B1 (fr) Composition medicamenteuse micronisee.
ES2054089T3 (es) Formulaciones orales liquidas.
ATE129146T1 (de) Stiftzusammensetzung enthaltend salzsäurenatrium und stearylalkohol.
ES2088877T3 (es) Procedimiento de preparacion del 3-pirrolidinol.
DE69207777T2 (de) Körperpflegemittel
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
MX9201482A (es) Acidos carboxilicos opticamente activos, proceso para su preparacion y composiciones farmaceuticas que los contienen.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
ES2054029T3 (es) Formulacion de acetato de flecainida con liberacion controlada.
DK138191D0 (da) Salicylsyreholdigt middel til behandling af afskallende hudlidelser
GR77250B (es)
DE3777411D1 (de) Mittel zur verbesserung der perkutanen verabreichung von arzneimitteln.
MX9304283A (es) Derivados de tiadiazinona, procedimiento para su preparacion y preparacion farmaceutica que los con tienen.
ES1020443Y (es) Dispositivo para aliviar las incomodidades del cuerpo humano durante su permanencia en posiciones forzadas.
MX9203260A (es) Derivados anillados del acido tetrahidropiridinacetico y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 469064

Country of ref document: ES